Novimmune SA

Company Profile Information

Company Description

Since 2000, NovImmune has raised CHF 92 million in 3 rounds of financing. Its main investors are: BZ Bank Ingro Finanz Varuma Pictet Novartis Venture Fun

Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.

More Company Info

SIC Codes




Recently updated profiles at this company
(76 contacts available)
Marie Kosco-Vilbois
Chief Scientific Officer
Maureen Deehan
Business Development and Scientific Licensing Lead
Robert Nelson
Head of Bioanalytical Assay Laboratory
Florence Guilhot
Scientific Project Manager
Emmanuel Monnet
Senior Clinical Science Leader
  • View Contact Info >>
  • Contact people at this company
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.